Talk:Miles Vaughan Williams

From WikiProjectMed
Jump to navigation Jump to search

Singh

There have been some recent edits related to the contribution by Singh, but these contributions have been reversed (by others) as unreferenced. In case this occurs again, I though that I'd start a discussion here about the classification system. The Singh DPhil thesis referred to, according to the Oxford library catalogue is:

Singh, B. N. (Bramah N.)(1971) A study of the pharmacological actions of certain drugs and hormones with particular reference to cardiac muscle. x, 155 leaves : illustrations ; 27 cm

Key joint papers between Singh and Vaughan Williams were published in 1970,[1][2] which appear to relate to amiodarone and other Class III compounds.

There is a broader article on antidysrhymic drugs by Vaughan-Williams in 1970,[3] and there are a flurry of 1969 articles from Vaughan-Williams and others (but not Singh) discussing antidysrthymic drugs.[4][5][6][7]

Vaughan-Williams had a clear interest, and published on, cardiac arrhythmias back from his time working with Burn in 1956,[8] and developed important experimental techniques necessary for study such arrthymias in the 1950s.[9]

So, to my eye, its not clear that Singh had a leading role, and that contributions of many others were equally important (and earlier), with Vaughan-Williams leading the line of enquiry. Klbrain (talk) 17:07, 20 July 2017 (UTC)[reply]

References

  1. ^ Singh, BN; Vaughan Williams, EM (August 1970). "A third class of anti-arrhythmic action. Effects on atrial and ventricular intracellular potentials, and other pharmacological actions on cardiac muscle, of MJ 1999 and AH 3474". British journal of pharmacology. 39 (4): 675–87. PMID 5485144.
  2. ^ Singh, BN; Vaughan Williams, EM (August 1970). "The effect of amiodarone, a new anti-anginal drug, on cardiac muscle". British journal of pharmacology. 39 (4): 657–67. PMID 5485142.
  3. ^ Vaughan Williams, EM (1970). "The experimental basis for the choice of an anti-arrhythmic drug". Advances in cardiology. 4: 275–89. PMID 4395423.
  4. ^ Papp, JG; Vaughan Williams, EM (October 1969). "The effect of bretylium on intracellular cardiac action potentials in relation to its anti-arrhythmic and local anaesthetic activity". British journal of pharmacology. 37 (2): 380–90. PMID 5348427.
  5. ^ Dohadwalla, AN; Freedberg, AS; Vaughan Williams, EM (June 1969). "The relevance of beta-receptor blockade to ouabain-induced cardiac arrhythmias". British journal of pharmacology. 36 (2): 257–67. PMID 5787666.
  6. ^ Vaughan Williams, EM; Dohadwalla, AN (10 May 1969). "Diarrhoea and intestinal fluid accumulation in uninfected rabbits cross perfused with blood from donor rabbits intra-intestinally infected with cholera". Nature. 222 (5193): 586–7. PMID 5786503.
  7. ^ Papp, JG; Vaughan Williams, EM (May 1969). "The effect of some catecholamine beta-receptor blocking compounds on the toxicity to the heart of ouabain". British journal of pharmacology. 36 (1): 178P–179P. PMID 5768092.
  8. ^ BURN, JH; VAUGHAN WILLIAMS, EM; WALKER, JM (28 February 1956). "The formation of acetylcholine in the heart; its effect on the systemic output and its importance for auricular fibrillation caused by aconitine". The Journal of physiology. 131 (2): 317–28. PMID 13320337.
  9. ^ VAUGHAN WILLIAMS, EM (9 May 1959). "Relation of extracellular to intracellular potential records from single cardiac muscle fibres". Nature. 183 (4671): 1341–2. PMID 13657117.

"You Don't Need a Gym"

Is that book really by the same guy as the article? It doesn't seem like it. Penguinmlle (talk) 17:17, 19 May 2022 (UTC)[reply]

Odd but true; I have a copy, and have talked to him about it. Interesting what one decides to do post-retirement! Klbrain (talk) 13:52, 8 February 2024 (UTC)[reply]
Retrieved from "https://mdwiki.org/wiki/Talk:Miles_Vaughan_Williams"